The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.
Credit: National Foundation for Cancer Research, RadioMedix, TanoMed, Tel Aviv University, Libera Bio
ROCKVILLE, MD - The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.
The semi-finalists were determined earlier in the spring based upon applications from among academic laboratories or early-stage companies advancing promising experimental cancer therapeutic, diagnostic, detection and vaccine innovations.
The first prize winner of the Salisbury Award Competition is the cancer therapeutic innovation presented by Ronit Satchi-Fainaro, Ph.D., co-founder and chief scientific officer (CSO) of Israel-based TanoMed, and a professor at Tel Aviv University and director of its Cancer Bio
Asian Fund for Cancer Research Announces Inaugural BRACE Award Venture Competition Winner | Taiwan News taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.
Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced
Share Article ROCKVILLE, Md. (PRWEB) February 22, 2021 Privo Technologies and its chief executive officer, Manijeh Goldberg, Ph.D., have been selected as the winner of the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition, a first of its kind program for female entrepreneurs starting oncology companies.
Privo Technologies has developed a nano-engineered platform for redesigning the mechanism of action of potent cancer medicines. The company was selected from among 47 female-led oncology start-ups following rigorous review and evaluation by three blue ribbon committees. As a result, Privo Technologies has received investment totaling $900,000 $300,000 from AIM-HI and matching investments from two supporters of the Women’s Venture Competition.
Winner of the AIM-HI Accelerator Fund s Inaugural Women s Venture Competition Announced benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.